作为抗疟疾药物标的Metacaspase (Pf MCA-1):一种in silico方法及其生物验证

Kanchan Yadav1, Jitendra Kuldeep2, H Shabeer Ali3

  • 1Molecular Microbiology and Immunology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India; Department of Pathology and Immunology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.

Life sciences
|November 17, 2023
PubMed
概括

新的梅桥化合物通过向Plasmodium falciparum metacaspase-1.1,显示出抗疟疾活性. 这些候选药物通过包括增强蛋白酶活性和DNA分裂在内的机制来破坏寄生虫的生长.